Genmab A/SGMABNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank93
3Y CAGR+3.3%
5Y CAGR+8.5%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+3.3%/yr
vs +107.6%/yr prior
5Y CAGR
+8.5%/yr
Recent deceleration
Acceleration
-104.3pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.91B | +10.6% |
| 2024 | $9.86B | -33.7% |
| 2023 | $14.87B | +50.3% |
| 2022 | $9.89B | +10.4% |
| 2021 | $8.96B | +23.4% |
| 2020 | $7.26B | +104.4% |
| 2019 | $3.55B | +566.5% |
| 2018 | $532.91M | -60.5% |
| 2017 | $1.35B | +338.9% |
| 2016 | $307.02M | - |